510(k) Report

510(k) · Cleared

Cleared

SpiroSphere, SpiroSphereECG, CardioSphere

K223629510(k) TraditionalCleared May 28, 2024540-day reviewClass II21 CFR 868.1890

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Eresearchtechnology GmbH · BTY Calculator, Predicted Values, Pulmonary Function

Cleared on May 28, 2024 as substantially equivalent to K202754 (Eresearchtechnology GmbH, 2021) after a 540-day review. Its family tree reaches back 5 generations to 2000.

Decided
May 28, 2024
Review
540 days
Class
Class II
Product code
BTY
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K002074 (2000). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK002074 AB Cardiette Daedalus View Base and AB Cardiettte Daedalus View HesH&C Medical Devices Spa · 2000
  2. 4 generations backK070614 CorscreenViasys Healthcare GmbH · 2007
  3. 3 generations backK080734 Flowscreen, Flowscreen/Corscreen, Flowscreen CTViasys Healthcare GmbH · 2008
  4. 2 generations backK082539 Masterscope, Masterscope Ecg, Masterscope CTCardinal Health Germany 234 GmbH · 2008
  5. 1 generation backK202754 MasterScope, MasterScope CT, MasterScope ECG, MasterScope WSSUEresearchtechnology GmbH · 2021
  6. This deviceK223629 SpiroSphere, SpiroSphereECG, CardioSphereEresearchtechnology GmbH · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K002074AB Cardiette Daedalus View Base and AB Cardiettte Daedalus View HesH&C Medical Devices Spa2000—
−4K070614CorscreenViasys Healthcare GmbH2007—
−3K080734Flowscreen, Flowscreen/Corscreen, Flowscreen CTViasys Healthcare GmbH2008—
−2K082539Masterscope, Masterscope Ecg, Masterscope CTCardinal Health Germany 234 GmbH2008—
−1K202754MasterScope, MasterScope CT, MasterScope ECG, MasterScope WSSUEresearchtechnology GmbH2021—
0 (this device)K223629SpiroSphere, SpiroSphereECG, CardioSphereEresearchtechnology GmbH2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200720
FIG. 1 — Lineage of K223629, 2000–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BTY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BTY device

  1. #1 K260242 CPETWise Platformscore 13.1 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K202754MasterScope, MasterScope CT, MasterScope ECG, MasterScope WSSU
Summary page 7
…ndary) Reason for Premarket Notification New option (ECG) to a cleared device (SpiroSphere K173937) Legally Marketed Predicate and Reference Devices Predicate Device: K202754 Code BTY, DPS Masterscope, Masterscope ECG, Masterscope CT, Masterscope WSSU Reference Devices: K173937 Code BTY SpiroSphere K…
Eresearchtechnology GmbH2021—
†K173937SpiroSphereEresearchtechnology GmbH2019—
†K183369COR12 EcgCorscience GmbH & Co.2018—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 4 companies; a new generation was cleared every 3.3 years on median.
  • None of the 7 ancestors has a recall.

How does its category compare?

All BTY devices

BTY Calculator, Predicted Values, Pulmonary Function: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · BTY

3in 2024

2007: 22008: 32009: 12010: 12011: 12012: 32016: 12017: 12019: 22020: 12021: 12022: 12023: 12024: 32026 (partial year): 1
2007high 3 (2008) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BTY

266in 2024

2008: 104 days median2012: 139 days median2024: 266 days median
2007high 266 (2024) · low 104 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BTY

2in 2017

2014: 12017: 2
2007high 2 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BTY

5in 2024

2009: 12011: 32012: 22014: 12015: 512016: 242017: 92018: 52019: 32020: 32021: 22022: 22023: 12024: 5
2007high 51 (2015) · low 0 (2007)2025

MAUDE reports naming product code BTY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
2008310400
20091—01
20101—00
20111—03
2012313902
20130—00
20140—11
20150—051
20161—024
20171—29
20180—05
20192—03
20201—03
20211—02
20221—02
20231—01
2024326605
20250—00
20261—0—

What is it indicated for?

The SpiroSphere is a compact device to measure inspiratory and expiratory lung function parameters in adults and children aged 4 years and older. It can be used by physicians in the office or hospital. The SpiroSphere is a compact device to measure inspiratory and expiratory lung function parameters in adults and children aged 4 years and older. With the option ECG, electrocardiographic measurements can be made under resting conditions. For this purpose…

Read the full statement (416 words)

The SpiroSphere is a compact device to measure inspiratory and expiratory lung function parameters in adults and children aged 4 years and older.

It can be used by physicians in the office or hospital.

The SpiroSphere is a compact device to measure inspiratory and expiratory lung function parameters in adults and children aged 4 years and older.

With the option ECG, electrocardiographic measurements can be made under resting conditions. For this purpose a 12-channel surface electrocardiogram can be measured and recorded. The acquired ECG can be displayed on the screen or printed on paper. The interpretation software is intended to support the physician in evaluation of the resting ECG in terms of morphology and rhythm. Automatic interpretation of the ECG is not possible for pediatric subjects with an age below 16 years and for pacemaker subjects. It is not intended for intra-cardial use.

A qualified physician has to reassess all ECG measurements. An interpretation by SpiroSphere ECG is only significant if it is considered in connection with other clinical findings. ECG interpretation statements made by the SpiroSphere ECG represent partial qualitative and quantitative information on the patient's cardiovascular condition and no therapy or drugs can be administered based solely on the interpretation statements. The SpiroSphere ECG is not intended for use in an EMS environment (Emergency Medical Services Environment).

The minimum age for ECG application is 4 years.

It can be used by physicians in the office or hospital.

With the CardioSphere, electrocardiographic measurements can be made under resting conditions. For this purpose a 12-channel surface electrocardiogram can be measured and recorded. The acquired ECG can be displayed on the screen or printed on paper. The interpretation software is intended to support the physician in evaluation of the resting ECG in terms of morphology and rhythm. Automatic interpretation of the ECG is not possible for pediatric subjects with an age below 16 years and for pacemaker subjects. It is not intended for intra-cardial use.

A qualified physician has to reassess all ECG measurements. An interpretation by CardioSphere is only significant ifit is considered in connection with other clinical findings. ECG interpretation statements made by the CardioSphere represent partial qualitative and quantitative information on the patient's cardiovascular condition and no therapy or drugs can be administered based solely on the interpretation statements. The CardioSphere is not intended for use in an EMS environment (Emergency Medical Services Environment).

The minimum age for ECG application is 4 years.

It can be used by physicians in the office or hospital.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K223629: SpiroSphere, SpiroSphereECG, CardioSphere.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223629

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026